The Dynatron ThermoStim Probe™ is a soft-tissue mobilization tool that also allows a practitioner to deliver heat or cold therapy in combination with electrical stimulation—all at the same time. An optional accessory to our new SolarisPlus family of products, this revolutionary tool facilitates the delivery of three different therapies in one treatment, significantly reducing the time typically required to administer separate treatments.
"This groundbreaking probe is expected to generate significant demand – not only for the probe, but also for the new SolarisPlus units, which serve as the control consoles for the probe," reported Larry K. Beardall, executive vice president of sales and marketing. "By leveraging proprietary technology, the new ThermoStim Probe will be the catalyst to boost sales and attract new distributors, beginning midway through fiscal year 2014."The company expects that its large number of new product introductions will open new doors of distribution, and has begun an aggressive expansion of its distribution channels to capture greater market share.
During fiscal year 2013, Dynatronics reduced SG&A and R&D expenses by $935,000, which offset the $856,600 reduction in gross profit for the year. Management has identified an additional $500,000 in expense reductions for fiscal year 2014.
"We believe the introduction of a record number of products this last year and in the new fiscal year, together with the anticipated introduction of the Thermostim Probe, plus our new strategy for expanding the distribution of products, positions us well for a new growth phase," concluded Cullimore.
Dynatronics has scheduled a conf
|SOURCE Dynatronics Corporation|
Copyright©2012 PR Newswire.
All rights reserved